Patent · US Active

Heterobicyclic compounds for inhibiting the activity of SHP2

US12037345B2 · kind B2 · utility

0Cited by
2References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 23, 2019
Grant dateJul 16, 2024
Priority date
Expiry dateJul 7, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides a compound of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.